eli lilly gip glp-1 Lilly's retatrutide, a GIP/GLP-1/glucagon triple agonist, met Phase 3 endpoints, delivering 28.3% weight loss over 80 weeks in TRIUMPH-1. # EliLilly #Retatrutide #GLP1 #GIP #Glucagon #ObesityTreatment #Phase3 #TRIUMPH1 #WeightLossDrugs glp-1 gip lilly eli lilly
Description
GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.
Adipokines (e.g., leptin and adiponectin) are regulated by DPP-4 and may influence bone remodeling and energy metabolism in a paracrine manner
Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition
Not everyone responds equally to brand-name GLP-1 therapy
We weigh Authenticity at 22% of our score
Learn safe time limits, temperature rules, and travel tips to keep your injections effective.
